The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors
Open accessAbstract
Clinical trials identified intravitreal vascular endothelial growth factor inhibitors (anti-VEGF agents) have the potential to stabilise or even improve visual acuity outcomes in neovascular age-related macular degeneration (AMD), a sight-threatening disease. Real-world evidence allows us to assess whether results from randomised controlled trials can be applied to the general population. We describe the development of global registries, in particular the Fight Retinal Blindness! registry that originated in Australia, the United Kingdom AMD Electronic Medical Records User Group and the IRIS registry in the USA. Real-world observations relating to efficacy, safety and resource utilisation of intravitreal anti-VEGF therapy for neovascular AMD are then summarised. Novel observations that would have been challenging to identify in a clinical trial setting are then highlighted, including the risk of late disease reactivation, outcomes in second versus first treated eyes, and the increased risk of posterior capsular rupture during cataract surgery in patients who have received intravitreal anti-VEGF therapy. We conclude by exploring future directions in the field. This includes the development of a global consensus on real-world outcome measures to allow greater comparison of results. Real-world neovascular AMD outcome registries can be linked with other databases to determine systemic safety or genetic predictors of treatment efficacy. Machine learning offers opportunities to extract useful insights from "Big Data" often collected in these registries. Real-world registries could be used by drug regulatory authorities and industry as an alternative to more costly and time-consuming phase 4 clinical trials, potentially allowing medication costs to be based on outcomes achieved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Wong, W. L., Su, X., Li, X., Cheung, C. M. G., Klein, R., Cheng, C.-Y., & Wong, T. Y. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(13)70145-1 · Cited by 5,331
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration
Heier, J. S., Brown, D. M., Chong, V., Korobelnik, J.-F., Kaiser, P. K., Nguyen, Q. D., Kirchhof, B., Ho, A., Ogura, Y., Yancopoulos, G. D., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.09.006 · Cited by 2,485
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
New Visual Acuity Charts for Clinical Research
Ferris, F. L., Kassoff, A., Bresnick, G. H., & Bailey, I. (1982) · American Journal of Ophthalmology · doi:10.1016/0002-9394(82)90197-0 · Cited by 2,142
Real-World Evidence — What Is It and What Can It Tell Us?
Sherman, R. E., Anderson, S. A., Dal Pan, G. J., Gray, G. W., Gross, T., Hunter, N. L., LaVange, L., Marinac-Dabic, D., Marks, P. W., Robb, M. A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmsb1609216 · Cited by 2,063
Holmgren, L., O'Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,878
Causes of vision loss worldwide, 1990–2010: a systematic analysis
Bourne, R. R. A., Stevens, G. A., White, R. A., Smith, J. L., Flaxman, S. R., Price, H., Jonas, J. B., Keeffe, J., Leasher, J., Naidoo, K., et al. (2013) · The Lancet Global Health · doi:10.1016/s2214-109x(13)70113-x · Cited by 1,831
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
Martin, D. F., Maguire, M. G., Fine, S. L., Ying, G.-S., Jaffe, G. J., Grunwald, J. E., Toth, C., Redford, M., & Ferris, F. L. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.03.053 · Cited by 1,715
VEGF-Trap: A VEGF blocker with potent antitumor effects
Holash, J., Davis, S., Papadopoulos, N., Croll, S. D., Ho, L., Russell, M., Boland, P., Leidich, R., Hylton, D., Burova, E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398299 · Cited by 1,691
Why we need observational studies to evaluate the effectiveness of health care
Black, N. (1996) · BMJ · doi:10.1136/bmj.312.7040.1215 · Cited by 1,598
New Design Principles for Visual Acuity Letter Charts
Bailey, I. L., & Lovie, J. E. (1976) · American journal of optometry and physiological optic · doi:10.1002/j.2330-9512.1976.tb02218.x · Cited by 1,407
Age-related macular degeneration
Jager, R. D., Mieler, W. F., & Miller, J. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801537 · Cited by 1,379
Brown, D. M., Michels, M., Kaiser, P. K., Heier, J. S., Sy, J. P., & Ianchulev, T. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.10.018 · Cited by 1,318
Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration
Avery, R. L., Pieramici, D. J., Rabena, M. D., Castellarin, A. A., Nasir, M. A., & Giust, M. J. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.11.019 · Cited by 1,133
RECEPTIVE FIELDS OF CELLS IN STRIATE CORTEX OF VERY YOUNG, VISUALLY INEXPERIENCED KITTENS
Hubel, D. H., & Wiesel, T. N. (1963) · Journal of Neurophysiology · doi:10.1152/jn.1963.26.6.994 · Cited by 1,116
Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
Rofagha, S., Bhisitkul, R. B., Boyer, D. S., Sadda, S. R., & Zhang, K. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.03.046 · Cited by 1,023
Mechanisms of adverse effects of anti-VEGF therapy for cancer
Kamba, T., & McDonald, D. M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603813 · Cited by 990
Rosenfeld, P. J., Moshfeghi, A. A., & Puliafito, C. A. (2005) · Ophthalmic Surgery, Lasers and Imaging Retina · doi:10.3928/1542-8877-20050701-14 · Cited by 904
Lalwani, G. A., Rosenfeld, P. J., Fung, A. E., Dubovy, S. R., Michels, S., Feuer, W., Davis, J. L., Flynn, H. W., & Esquiabro, M. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.01.024 · Cited by 880
Regillo, C. D., Brown, D. M., Abraham, P., Yue, H., Ianchulev, T., Schneider, S., & Shams, N. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.10.004 · Cited by 858
Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration
Schmidt-Erfurth, U., Kaiser, P. K., Korobelnik, J.-F., Brown, D. M., Chong, V., Nguyen, Q. D., Ho, A. C., Ogura, Y., Simader, C., Jaffe, G. J., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.08.011 · Cited by 822
(2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)00967-9 · Cited by 814
Chakravarthy, U., Harding, S. P., Rogers, C. A., Downes, S. M., Lotery, A. J., Culliford, L. A., & Reeves, B. C. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61501-9 · Cited by 748 · cited 1×
“Randomised controlled trials comparing intravitreal ranibizumab and bevacizumab found similar efficacy for the treatment of nAMD (Chakravarthy et al., 2013; Martin et al., 2012).”
BackgroundMaguire, M. G., Martin, D. F., Ying, G.-S., Jaffe, G. J., Daniel, E., Grunwald, J. E., Toth, C. A., Ferris, F. L., & Fine, S. L. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.03.045 · Cited by 708
Age-Related Macular Degeneration Is the Leading Cause of Blindness . . .
Bressler, N. M. (2004) · JAMA · doi:10.1001/jama.291.15.1900 · Cited by 684
Bressler, N. M. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01237-5 · Cited by 666
MICHELS, S., ROSENFELD, P., PULIAFITO, C., MARCUS, E., & VENKATRAMAN, A. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.02.007 · Cited by 664
Deep Learning Is Effective for Classifying Normal versus Age-Related Macular Degeneration OCT Images
Lee, C. S., Baughman, D. M., & Lee, A. Y. (2017) · Ophthalmology Retina · doi:10.1016/j.oret.2016.12.009 · Cited by 657
Self-citationSPAIDE, R. F., LAUD, K., FINE, H. F., KLANCNIK, J. M., MEYERLE, C. B., YANNUZZI, L. A., SORENSON, J., SLAKTER, J., FISHER, Y. L., & COONEY, M. J. (2006) · Retina · doi:10.1097/00006982-200604000-00001 · Cited by 630
Multiple Imputation: A Flexible Tool for Handling Missing Data
Li, P., Stuart, E. A., & Allison, D. B. (2015) · JAMA · doi:10.1001/jama.2015.15281 · Cited by 621
Wood, A. M., White, I. R., & Thompson, S. G. (2004) · Clinical Trials · doi:10.1191/1740774504cn032oa · Cited by 543
Salathé, M., & Khandelwal, S. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002199 · Cited by 530
Salathé, M., Bengtsson, L., Bodnar, T. J., Brewer, D. D., Brownstein, J. S., Buckee, C., Campbell, E. M., Cattuto, C., Khandelwal, S., Mabry, P. L., et al. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002616 · Cited by 500
Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy
Thijssen, V. L. J. L., Postel, R., Brandwijk, R. J. M. G. E., Dings, R. P. M., Nesmelova, I., Satijn, S., Verhofstad, N., Nakabeppu, Y., Baum, L. G., Bakkers, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603883103 · Cited by 497
Michaelson, I. (1948) · Medical Entomology and Zoology · Cited by 448
Abraham, P., Yue, H., & Wilson, L. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.04.011 · Cited by 441
Argon Laser Photocoagulation for Senile Macular Degeneration: Results of a Randomized Clinical Trial
(1982) · Archives of Ophthalmology · doi:10.1001/archopht.1982.01030030920003 · Cited by 405
Withdrawal of Cerivastatin from the World Market
Furberg, C. D., & Pitt, B. (2001) · Trials · doi:10.1186/cvm-2-5-205 · Cited by 400
Rudnicka, A. R., Jarrar, Z., Wormald, R., Cook, D. G., Fletcher, A., & Owen, C. G. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2011.09.027 · Cited by 394
Berg, K., Pedersen, T. R., Sandvik, L., & Bragadóttir, R. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2014.07.041 · Cited by 392
A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration
Schmidt-Erfurth, U., & Waldstein, S. M. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.07.007 · Cited by 390
Incidence of Legal Blindness From Age-Related Macular Degeneration in Denmark: Year 2000 to 2010
Bloch, S. B., Larsen, M., & Munch, I. C. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.10.016 · Cited by 377
on behalf of all surgeons contributing towards The Royal College of Ophthalmologists’ National Ophthalmology Database, Day, A. C., Donachie, P. H. J., Sparrow, J. M., & Johnston, R. L. (2015) · Eye · doi:10.1038/eye.2015.3 · Cited by 364
Risk factors and biomarkers of age-related macular degeneration
Lambert, N. G., ElShelmani, H., Singh, M. K., Mansergh, F. C., Wride, M. A., Padilla, M., Keegan, D., Hogg, R. E., & Ambati, B. K. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.04.003 · Cited by 351
Missing.... presumed at random: cost‐analysis of incomplete data
Briggs, A., Clark, T., Wolstenholme, J., & Clarke, P. (2003) · Health Economics · doi:10.1002/hec.766 · Cited by 346
Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians
Wong, C. W., Yanagi, Y., Lee, W.-K., Ogura, Y., Yeo, I., Wong, T. Y., & Cheung, C. M. G. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.04.002 · Cited by 346
Antiangiogenic therapy of transgenic mice impairs de novo tumor growth.
Parangi, S., O'Reilly, M., Christofori, G., Holmgren, L., Grosfeld, J., Folkman, J., & Hanahan, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2002 · Cited by 344
Gillies, M. C. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.5.667 · Cited by 298
Self-citationMiller, J. W., Adamis, A. P., & Aiello, L. P. (1997) · Diabetes / Metabolism Reviews · doi:10.1002/(sici)1099-0895(199703)13:1<37::aid-dmr174>3.0.co;2-k · Cited by 297
(2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.11.031 · Cited by 283
Wykoff, C. C., Croft, D. E., Brown, D. M., Wang, R., Payne, J. F., Clark, L., Abdelfattah, N. S., & Sadda, S. R. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.08.009 · Cited by 275
A Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration
Gupta, O. P., Shienbaum, G., Patel, A. H., Fecarotta, C., Kaiser, R. S., & Regillo, C. D. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.032 · Cited by 272
The Price of Sight — Ranibizumab, Bevacizumab, and the Treatment of Macular Degeneration
Steinbrook, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068185 · Cited by 255
Long-term outcomes of treatment of neovascular age-related macular degeneration
Gillies, M. C., Campain, A., Barthelmes, D., Simpson, J. M., Arnold, J. J., Guymer, R. H., McAllister, I. L., Essex, R. W., Morlet, N., & Hunyor, A. P. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.05.010 · Cited by 254
Self-citationTolentino, M. J., Mcleod, D. S., Taomoto, M., Otsuji, T., Adamis, A. P., & Lutty, G. A. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01381-2 · Cited by 250
Fileta, J. B., Scott, I. U., & Flynn, H. W. (2014) · Ophthalmic Surgery, Lasers and Imaging Retina · doi:10.3928/23258160-20140306-08 · Cited by 242
Avery, R. L., & Gordon, G. M. (2016) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2015.4070 · Cited by 217
Kaiser, P. K., Blodi, B. A., Shapiro, H., & Acharya, N. R. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.04.030 · Cited by 217
Tufail, A., Patel, P. J., Egan, C., Hykin, P., da Cruz, L., Gregor, Z., Dowler, J., Majid, M. A., Bailey, C., Mohamed, Q., et al. (2010) · BMJ · doi:10.1136/bmj.c2459 · Cited by 213
Self-citationSchmidt-Erfurth, U., Bogunovic, H., Sadeghipour, A., Schlegl, T., Langs, G., Gerendas, B. S., Osborne, A., & Waldstein, S. M. (2018) · Ophthalmology Retina · doi:10.1016/j.oret.2017.03.015 · Cited by 199
Cohen, S. Y., Mimoun, G., Oubraham, H., Zourdani, A., Malbrel, C., Queré, S., & Schneider, V. (2013) · Retina · doi:10.1097/iae.0b013e31827b6324 · Cited by 198
Anti-vascular endothelial growth factor for diabetic macular oedema
Virgili, G., Parravano, M., Menchini, F., & Evans, J. R. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007419.pub4 · Cited by 184
Kim, L. N., Mehta, H., Barthelmes, D., Nguyen, V., & Gillies, M. C. (2016) · Retina · doi:10.1097/iae.0000000000001142 · Cited by 184
Self-citationArnold, J. J., Campain, A., Barthelmes, D., Simpson, J. M., Guymer, R. H., Hunyor, A. P., McAllister, I. L., Essex, R. W., Morlet, N., Gillies, M. C., et al. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.02.009 · Cited by 181
Self-citationMcNamara, R. L., Spatz, E. S., Kelley, T. A., Stowell, C. J., Beltrame, J., Heidenreich, P., Tresserras, R., Jernberg, T., Chua, T., Morgan, L., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.001767 · Cited by 179
(1991) · Archives of Ophthalmology · doi:10.1001/archopht.1991.01080090056026 · Cited by 177
GASS, J. D. M., AGARWAL, A., LAVINA, A. M., & TAWANSY, K. A. (2003) · RETINA · doi:10.1097/00006982-200312000-00001 · Cited by 174
Lamoureux, E. L., Pallant, J. F., Pesudovs, K., Rees, G., Hassell, J. B., & Keeffe, J. E. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0361 · Cited by 165
The Psychometric Validity of the NEI VFQ-25 for Use in a Low-Vision Population
Marella, M., Pesudovs, K., Keeffe, J. E., O’Connor, P. M., Rees, G., & Lamoureux, E. L. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4494 · Cited by 165
Does analysis using "last observation carried forward" introduce bias in dementia research?
Molnar, F., Hutton, B., & Fergusson, D. A. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080820 · Cited by 162
Finger, R. P., Wiedemann, P., Blumhagen, F., Pohl, K., & Holz, F. G. (2012) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2012.02493.x · Cited by 161
(2004) · Ophthalmology · doi:10.1016/j.ophtha.2004.07.021 · Cited by 160
(1993) · Archives of Ophthalmology · doi:10.1001/archopht.1993.01090090041018 · Cited by 160
Gillies, M. C., Walton, R., Liong, J., Arnold, J., McAllister, I. L., Morlet, N., Hunyor, A. P., Guymer, R. H., Keeffe, J., Essex, R. W., et al. (2013) · Retina · doi:10.1097/iae.0b013e318296b271 · Cited by 152
Self-citationVision-Related Function after Ranibizumab Treatment by Better- or Worse-Seeing Eye
Bressler, N. M., Chang, T. S., Suñer, I. J., Fine, J. T., Dolan, C., Ward, J., & Ianchulev, T. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.09.002 · Cited by 150
Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration
Finger, R. P., Wickremasinghe, S. S., Baird, P. N., & Guymer, R. H. (2014) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2013.03.009 · Cited by 144
FALKENSTEIN, I. A., Cochran, D. E., Azen, S. P., Dustin, L., Tammewar, A. M., Kozak, I., & Freeman, W. R. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.05.028 · Cited by 141
Wykoff, C. C., Ou, W. C., Brown, D. M., Croft, D. E., Wang, R., Payne, J. F., Clark, W. L., Abdelfattah, N. S., & Sadda, S. R. (2017) · Ophthalmology Retina · doi:10.1016/j.oret.2016.12.004 · Cited by 135
Holz, F. G., Tadayoni, R., Beatty, S., Berger, A. R., Cereda, M. G., Hykin, P. G., Staurenghi, G., Wittrup-Jensen, K., Altemark, A., Nilsson, J., et al. (2016) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2015-308166 · Cited by 130
Abedi, F., Wickremasinghe, S., Islam, A. F. M., Inglis, K. M., & Guymer, R. H. (2014) · Retina · doi:10.1097/iae.0000000000000134 · Cited by 126
the UK EPR user group, Sparrow, J. M., Taylor, H., Qureshi, K., Smith, R., Birnie, K., & Johnston, R. L. (2012) · Eye · doi:10.1038/eye.2012.51 · Cited by 114
Defining a Minimum Set of Standardized Patient-centered Outcome Measures for Macular Degeneration
Rodrigues, I. A. S., Sprinkhuizen, S. M., Barthelmes, D., Blumenkranz, M. S., Cheung, C. M. G., Haller, J. A., Johnston, R. L., Ramasamy, K., Klaver, C. C. W., McKibbin, M., et al. (2016) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2016.04.012 · Cited by 113
Self-citationDaïen, V., Nguyen, V., Essex, R. W., Morlet, N., Barthelmes, D., Gillies, M. C., Gillies, M. C., Hunt, A., Essex, R. W., Dayajeewa, C., et al. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.07.005 · Cited by 110
Self-citationTalks, J. S., Lotery, A. J., Ghanchi, F. D., Sivaprasad, S., Johnston, R. L., Patel, N., McKibbin, M., Bailey, C., Mahmood, S., Lobo, A., et al. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.09.039 · Cited by 104
The Neovascular Age-Related Macular Degeneration Database
Zarranz-Ventura, J., Liew, G., Johnston, R. L., Xing, W., Akerele, T., McKibbin, M., Downey, L., Natha, S., Chakravarthy, U., Bailey, C., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.04.026 · Cited by 103
Self-citationBarthelmes, D., Nguyen, V., Daïen, V., Campain, A. E., Walton, R., Guymer, R. H., Morlet, N., Hunyor, A. P., Essex, R. W., Arnold, J., et al. (2017) · Retina · doi:10.1097/iae.0000000000001496 · Cited by 98
Self-citationEarly detection and treatment of neovascular age-related macular degeneration.
Bressler, N. M. (2002) · PubMed · Cited by 90
da Silva, R. M., Axer‐Siegel, R., Eldem, B., Guymer, R. H., Kirchhof, B., Papp, A., Seres, A., Gekkieva, M., Nieweg, A., & Pilz, S. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.07.026 · Cited by 89
Wolf, A., & Kampik, A. (2014) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-013-2562-6 · Cited by 87
Abedi, F., Wickremasinghe, S., Richardson, A. J., Makalic, E., Schmidt, D. F., Sandhu, S. S., Baird, P. N., & Guymer, R. H. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.10.006 · Cited by 85
Lotery, A., Griner, R., Ferreira, A., Milnes, F., & Dugel, P. (2017) · Eye · doi:10.1038/eye.2017.143 · Cited by 84
Bressler, S. B., Almukhtar, T., Bhorade, A. M., Bressler, N. M., Glassman, A. R., Huang, S. S., Jampol, L. M., Kim, J. E., & Melia, M. (2015) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2015.186 · Cited by 77
Radiotherapy for neovascular age-related macular degeneration
Evans, J. R., Sivagnanavel, V., & Chong, V. N. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004004.pub3 · Cited by 76
Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery
Eadie, B. D., Etminan, M., Carleton, B., Maberley, D., & Mikelberg, F. S. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.0059 · Cited by 74
Goldberg, R. A., Flynn, H. W., Miller, D., Gonzalez, S., & Isom, R. F. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.12.009 · Cited by 70
Laíns, I., Duarte, D., Barros, A. S., Martins, A. S., Gil, J., Miller, J. B., Marques, M., Mesquita, T., Kim, I. K., Cachulo, M. L., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177749 · Cited by 69
Gillies, M. C., Nguyen, V., Daïen, V., Arnold, J., Morlet, N., & Barthelmes, D. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.08.016 · Cited by 68
Self-citationLee, A., Lee, C. S., Butt, T., Xing, W., Johnston, R. L., Chakravarthy, U., Egan, C. A., Akerele, T., McKibbin, M., Downey, L., et al. (2015) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2014-306229 · Cited by 65
Self-citationMinassian, D. C., Reidy, A., Lightstone, A., & Desai, P. (2011) · British Journal of Ophthalmology · doi:10.1136/bjo.2010.195370 · Cited by 65
Finger, R. P., Guymer, R. H., Gillies, M. C., & Keeffe, J. E. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.12.032 · Cited by 63
Self-citationHjelmqvist, L., Lindberg, C., Kanulf, P., Dahlgren, H., Johansson, I., & Siewert, A. (2011) · Journal of Ophthalmology · doi:10.1155/2011/405724 · Cited by 62
Lee, A., Day, A. C., Egan, C. A., Bailey, C., Johnston, R. L., Tsaloumas, M. D., Denniston, A. K., Tufail, A., Akerele, T., Al-Husainy, S., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.02.014 · Cited by 59
Self-citationSouied, E. H., Oubraham, H., Mimoun, G., Cohen, S. Y., Quéré, S., & Derveloy, A. (2015) · Retina · doi:10.1097/iae.0000000000000548 · Cited by 59
Essex, R. W., Nguyen, V., Walton, R., Arnold, J., McAllister, I. L., Guymer, R. H., Morlet, N., Young, S. H., Barthelmes, D., & Gillies, M. C. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.07.012 · Cited by 55
Self-citationEleftheriadou, M. I., Vázquez-Alfageme, C., Citu, M. C., Crosby‐Nwaobi, R., Sivaprasad, S., Hykin, P. G., HAMILTON, R. D., & Patel, P. J. (2016) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2016.09.038 · Cited by 53
Heimes, B., Lommatzsch, A. P., Zeimer, M. B., Gutfleisch, M., Spital, G., Dietzel, M., & Pauleikhoff, D. (2010) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-010-1524-5 · Cited by 51
Shalchi, Z., Okada, M., Whiting, C., & HAMILTON, R. D. (2017) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2017.02.006 · Cited by 51
Tomita, Y., Ozawa, N., Miwa, Y., Ishida, A., Ohta, M., Tsubota, K., & Kurihara, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235878 · Cited by 50
Johnston, R. L., Carius, H.-J., Skelly, A., Ferreira, A., Milnes, F., & Mitchell, P. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0483-1 · Cited by 49
Ross, A. H., Donachie, P. H. J., Sallam, A. B., STRATTON, I. M., Mohamed, Q. A., Scanlon, P. H., Kirkpatrick, J. N., & Johnston, R. L. (2012) · Eye · doi:10.1038/eye.2012.225 · Cited by 48
Gillies, M. C., Daïen, V., Nguyen, V., & Barthelmes, D. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2016.05.054 · Cited by 48
Self-citationLee, A., Lee, C. S., Egan, C. A., Bailey, C., Johnston, R. L., Natha, S., HAMILTON, R. D., Khan, R. S., Al‐Husainy, S., Brand, C., et al. (2017) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2016-309818 · Cited by 46
Self-citationBarthelmes, D., Campain, A. E., Nguyen, P. V., Arnold, J., McAllister, I. L., Simpson, J. M., Hunyor, A. P., Guymer, R. H., Essex, R. W., Morlet, N., et al. (2016) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2015-308090 · Cited by 45
Self-citationCurrent phase 1/2 research for neovascular age-related macular degeneration
Pecen, P. E., & Kaiser, P. K. (2015) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000147 · Cited by 43
Borooah, S., Jeganathan, V. S. E., Armbrecht, A. M., Oladiwura, D., Gavin, M., Dhillon, B., & Cackett, P. (2015) · Eye · doi:10.1038/eye.2015.83 · Cited by 42
Menghini, M., Kloeckener‐Gruissem, B., Fleischhauer, J. C., Kurz-Levin, M. M., Sutter, F. K. P., Berger, W., & Barthelmes, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042014 · Cited by 41
Self-citationPushpoth, S., Sykakis, E., Merchant, K., Browning, A. C., Gupta, R., & Talks, J. S. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2012-302167 · Cited by 40
Rate of intraoperative complications during cataract surgery following intravitreal injections
Hahn, P., Jiramongkolchai, K., Stinnett, S. S., Daluvoy, M. B., & Kim, T. (2016) · Eye · doi:10.1038/eye.2016.109 · Cited by 38
UK Age-Related Macular Degeneration Electronic Medical Record System (AMD EMR) Users Group Report IV
Johnston, R. L., Lee, A., Buckle, M., Antcliff, R. J., Bailey, C., McKibbin, M., Chakravarthy, U., & Tufail, A. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.07.037 · Cited by 38
Self-citationKumar, A., Sahni, J., Stangos, A. N., Campa, C., & Harding, S. P. (2010) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.171868 · Cited by 35
van Asten, F., Evers‐Birkenkamp, K. U., van Lith-Verhoeven, J. J. C., de Jong‐Hesse, Y., Hoppenreijs, V. P. T., Hommersom, R. F., Scholten, A. M., Hoyng, C. B., Klaver, J. H. J., & the HELIOS study group (2014) · Acta Ophthalmologica · doi:10.1111/aos.12610 · Cited by 31
Gabai, A., Veritti, D., & Lanzetta, P. (2013) · European Journal of Ophthalmology · doi:10.5301/ejo.5000385 · Cited by 29
Keenan, T. D. L., Kelly, S. P., Sallam, A., Mohamed, Q., Tufail, A., & Johnston, R. L. (2013) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-303233 · Cited by 29
Self-citationOzturk, M., Harris, M. L., Nguyen, V., Barthelmes, D., Gillies, M. C., & Mehta, H. (2017) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13085 · Cited by 29
Self-citationNg, W. Y., Tan, G. S. W., Ong, P. G., Cheng, C., Cheung, C. Y.-L., Wong, D. W. K., Mathur, R., Chow, K. Y., Wong, T. Y., & Cheung, C. M. G. (2014) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2014.12.005 · Cited by 28
Treatment Patterns for Myopic Choroidal Neovascularization in the United States
Willis, J. R., Morse, L. S., Vitale, S., Parke, D. W., Rich, W. L., Lum, F., & Cantrell, R. A. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.02.018 · Cited by 28
Gillies, M. C., Campain, A. E., Walton, R., Simpson, J. M., Arnold, J., Guymer, R. H., McAllister, I. L., Hunyor, A. P., Essex, R. W., Morlet, N., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.10.001 · Cited by 27
Self-citationMadhusudhana, K. C., Lee, A., Keane, P. A., Chakravarthy, U., Johnston, R. L., Egan, C. A., Sim, D. A., Zarranz‐Ventura, J., Tufail, A., & McKibbin, M. (2016) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2015-308077 · Cited by 26
Self-citationTwenty‐four‐hour intraocular pressure patterns in patients with thyroid eye disease
Parekh, A. S., Mansouri, K., Weinreb, R. N., Tafreshi, A., Korn, B. S., & Kikkawa, D. O. (2014) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12400 · Cited by 23
Frennesson, C. I., & NILSSON, S. E. G. (2013) · Acta Ophthalmologica · doi:10.1111/aos.12091 · Cited by 22
Barthelmes, D., Walton, R., Campain, A. E., Simpson, J. M., Arnold, J., McAllister, I. L., Guymer, R. H., Hunyor, A. P., Essex, R. W., Morlet, N., et al. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2014-305514 · Cited by 21
Self-citationon behalf of UK AMD EMR Users Group, Liew, G., Lee, A., Zarranz‐Ventura, J., STRATTON, I. M., Bunce, C., Chakravarthy, U., Lee, C., Keane, P. A., Sim, D. A., et al. (2016) · Eye · doi:10.1038/eye.2016.149 · Cited by 20
Self-citationYang, Y. C., Downey, L., Mehta, H., Mushtaq, B., Narendran, N., Patel, N., Patel, P. J., Ayan, F., Gibson, K., Igwe, F., et al. (2017) · Ophthalmology and Therapy · doi:10.1007/s40123-017-0091-9 · Cited by 19
Self-citationVaze, A., Fraser‐Bell, S., & Gillies, M. C. (2014) · Acta Ophthalmologica · doi:10.1111/aos.12417 · Cited by 18
Self-citationChavan, R., Panneerselvam, S., Adhana, P., Narendran, N., & Yang, Y. C. (2014) · Clinical ophthalmology · doi:10.2147/opth.s60763 · Cited by 17
Westborg, I., Albrecht, S., & Rosso, A. (2017) · Retina · doi:10.1097/iae.0000000000001431 · Cited by 17
Intravitreal Therapy in Bilateral Neovascular Age-Related Macular Degeneration
Barthelmes, D., Walton, R., Arnold, J., McAllister, I. L., Simpson, J. M., Campain, A. E., Hunyor, A. P., Guymer, R. H., Essex, R. W., Morlet, N., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.05.007 · Cited by 13
Self-citationEsen, F., Alhan, Ö., Bektaşoğlu, P. K., & Şahin, Ö. (2016) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2016.06.019 · Cited by 13
VISUAL ACUITY IMPROVEMENT WHEN SWITCHING FROM RANIBIZUMAB TO AFLIBERCEPT IS NOT SUSTAINED
Lee, C. S., Kim, A. J., Baughman, D. M., Egan, C. A., Bailey, C., Johnston, R. L., Natha, S., Khan, R. S., Brand, C., Akerele, T., et al. (2017) · Retina · doi:10.1097/iae.0000000000001637 · Cited by 13
Self-citationRazavi, H., Arnold, J., & Guymer, R. H. (2015) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12658 · Cited by 6
Karaçorlu, M., Hocaoğlu, M., Arf, S., Ersöz, M. G., & Muslubaş, I. S. (2019) · Turkish Journal of Ophthalmology · doi:10.4274/tjo.galenos.2019.26235 · Cited by 5
Cited by
Artificial intelligence in retina
Schmidt-Erfurth, U., Sadeghipour, A., Gerendas, B. S., Waldstein, S. M., & Bogunović, H. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.07.004 · Cited by 779
Central serous chorioretinopathy: Towards an evidence-based treatment guideline
van Rijssen, T. J., van Dijk, E. H. C., Yzer, S., Ohno-Matsui, K., Keunen, J. E. E., Schlingemann, R. O., Sivaprasad, S., Querques, G., Downes, S. M., Fauser, S., et al. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.07.003 · Cited by 478
Mettu, P. S., Allingham, M. J., & Cousins, S. W. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100906 · Cited by 370
Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives
Kim, H. M., & Woo, S. J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010108 · Cited by 198
Monés, J., Singh, R. P., Bandello, F., Souied, E., Liu, X., & Gale, R. (2020) · Ophthalmologica · doi:10.1159/000502747 · Cited by 110
Metadata
- Authors
- Mehta, H., Tufail, A., Daien, V., Lee, A. Y., Nguyen, V., Ozturk, M., Barthelmes, D., & Gillies, M. C.
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 65
- Pages
- 127-146
- ISSN
- 1350-9462 (ISSN-L)
- OpenAlex
- W2782057573
- Cited by
- 265
- References
- 147
- FWCI
- 28.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.